HUP0300875A3 - Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine - Google Patents

Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Info

Publication number
HUP0300875A3
HUP0300875A3 HU0300875A HUP0300875A HUP0300875A3 HU P0300875 A3 HUP0300875 A3 HU P0300875A3 HU 0300875 A HU0300875 A HU 0300875A HU P0300875 A HUP0300875 A HU P0300875A HU P0300875 A3 HUP0300875 A3 HU P0300875A3
Authority
HU
Hungary
Prior art keywords
olanzapine
hydrates
conversion
preparation
crystalline forms
Prior art date
Application number
HU0300875A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Reddy S Lab Ltd Hyderabad Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Lab Ltd Hyderabad Dr filed Critical Reddy S Lab Ltd Hyderabad Dr
Publication of HUP0300875A2 publication Critical patent/HUP0300875A2/hu
Publication of HUP0300875A3 publication Critical patent/HUP0300875A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300875A 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine HUP0300875A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN709CH2000 2000-08-31
IN711CH2000 2000-08-31
PCT/US2001/007258 WO2002018390A1 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Publications (2)

Publication Number Publication Date
HUP0300875A2 HUP0300875A2 (hu) 2003-12-29
HUP0300875A3 true HUP0300875A3 (en) 2005-09-28

Family

ID=26324874

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300875A HUP0300875A3 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Country Status (12)

Country Link
EP (1) EP1313742A1 (sk)
JP (1) JP2004507548A (sk)
AU (1) AU2001243475A1 (sk)
BR (1) BR0114031A (sk)
CA (1) CA2420987A1 (sk)
CZ (1) CZ2003566A3 (sk)
HU (1) HUP0300875A3 (sk)
IL (1) IL154688A0 (sk)
NO (1) NO20030926L (sk)
RU (1) RU2003108745A (sk)
SK (1) SK2502003A3 (sk)
WO (1) WO2002018390A1 (sk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1440074A1 (en) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002251329A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
EP1513846B1 (en) 2002-05-31 2011-03-02 Sandoz Ag Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
PL1611139T3 (pl) 2003-12-22 2008-10-31 Teva Pharma Sposób wytwarzania olenzapiny
AR047459A1 (es) 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
EP1711503A1 (en) * 2004-01-27 2006-10-18 Synthon B.V. Synthesis of olanzapine and intermediates thereof
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2005107375A2 (en) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Process for the preparation of olanzapine form-i
US8044196B2 (en) 2004-07-14 2011-10-25 Jubilant Organosys Limited Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006025065A1 (en) * 2004-08-31 2006-03-09 Lee Pharma Private Limited A process for the preparation of anhydrous olanzopine hydrochloride of form-1
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat
KR20070113277A (ko) * 2005-03-21 2007-11-28 닥터 레디스 레보러터리즈 리미티드 올란자핀의 결정 형태 ｉ의 제조방법
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
EP2185566A2 (en) * 2007-05-15 2010-05-19 Generics Ýuk¨Limited Process for the purification of olanzapine
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
CN102093386B (zh) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 一种制备奥兰扎平晶型ⅱ的方法
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法
SG11201810704WA (en) 2016-05-31 2018-12-28 Taiho Pharmaceutical Co Ltd Sulfonamide compound or salt thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
RS49597B (sr) * 1996-09-23 2007-06-04 Eli Lilly And Company, Olanzapin dihidrat d
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine

Also Published As

Publication number Publication date
WO2002018390A1 (en) 2002-03-07
AU2001243475A1 (en) 2002-03-13
CA2420987A1 (en) 2002-03-07
NO20030926D0 (no) 2003-02-27
RU2003108745A (ru) 2005-01-10
NO20030926L (no) 2003-04-24
BR0114031A (pt) 2003-09-09
SK2502003A3 (en) 2004-03-02
EP1313742A1 (en) 2003-05-28
HUP0300875A2 (hu) 2003-12-29
IL154688A0 (en) 2003-09-17
CZ2003566A3 (cs) 2004-01-14
JP2004507548A (ja) 2004-03-11

Similar Documents

Publication Publication Date Title
HUP0300875A3 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
HK1089447A1 (en) A process for the preparation of 2-aminocarbonyl-9h-purine derivatives and the intermediates thereof
SG92703A1 (en) Method of producing profiled sheets as prosthesis
HU0100033D0 (en) Stuffed foodproduct and process for its production and equipment for realization of process
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
PL361277A1 (en) Use of thienopyrimidines
AU2001290311A1 (en) Thienopyrimidine compounds and their salts and process for preparation of both
HUP0300591A3 (en) Process for preparing crystalline form i of cabergoline
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
GB0007307D0 (en) Crystalline form || of cabergoline
GB0007309D0 (en) Crystalline form V|| of cabergoline
PL340132A1 (en) Method of obtaining modified microcrystalline chitosamine
AU1396502A (en) Amorphous form of cell cycle inhibitor
HUP0303907A3 (en) Improved process for preparation of steroids
PL345527A1 (en) Method of makinbg glassware
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
PL361052A1 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
HU0103554D0 (en) Method for production of methylene-karbamide polimers
HU0104563D0 (en) Process for producing of food-enzymes
AU8626801A (en) Method of forming complex
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
IL140096A0 (en) Process for preparation of zafirlukast
HU0001829D0 (en) Process for making of sorb-spirit